Abstract
Since the citadel of privity first crumbled for manufacturers of defective products decades ago, state and federal courts have expanded the foundations of products liability law to include not only purchasers as plaintiffs but “ultimate” bystanders under notions of reasonableness, foreseeability and risk allocation. 3 During this time, products such as drugs, blood products and medical devices have come to be viewed as distinct from other commodities, particularly with the coming of the Restatement (Third) of Torts: Products Liability.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Pittsburgh Journal of Environmental and Public Health Law
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
